Cargando…
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this path and screened approved medications "off-label" against SARS-CoV-2. Fluoxetine inhibited SARS-CoV-2 at a...
Autores principales: | Zimniak, Melissa, Kirschner, Luisa, Hilpert, Helen, Geiger, Nina, Danov, Olga, Oberwinkler, Heike, Steinke, Maria, Sewald, Katherina, Seibel, Jürgen, Bodem, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961020/ https://www.ncbi.nlm.nih.gov/pubmed/33723270 http://dx.doi.org/10.1038/s41598-021-85049-0 |
Ejemplares similares
-
Acetylsalicylic Acid and Salicylic Acid Inhibit SARS-CoV-2 Replication in Precision-Cut Lung Slices
por: Geiger, Nina, et al.
Publicado: (2022) -
Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011) -
Treatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia response
por: Panlilio, Jennifer M., et al.
Publicado: (2016) -
Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023) -
Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals
por: Briscoe, Vanessa J., et al.
Publicado: (2008)